Serum institute of india pvt. ltd, Company

Bengaluru, April 12 Predictive studies opine that the 4th wave of the Covid-19 will start in June-July and last till September, stated Karnataka Health Minister K. Sudhakar on Tuesday. "Karnataka is prepared to face it," he added.He said that there is no need to worry as of now. The new XE variant of Covid-19 is prominent in 8 countries and people arriving from that country are being screened, he said. Answering a question, he said that the mask is still essential and there will be no relaxation but said that there is no need to worry about the 4th wave. 5,000 children in the age group 6-12 who are not yet eligible for vaccine will be said.Speaking about India's vaccination progress, Sudhakar pointed out that many vaccines previously given to kids reached India a long time after they were available elsewhere in the world. "I don't want to bring politics in this collective fight against pandemic, but people should know this. During the last 70 years when other parties ruled, vaccines came much later to India compared to the rest of the world."Hepatitis B vaccine was introduced across the world in 1985 but came to India only by 2005. Compared to the rest of the world, the BCG vaccine came 20-25 years later and the Japanese Encephalitis vaccine came 45 years later. However, the first Covid case was found on January 30, 2020 and within a year, by January 16, 2021 India had introduced the vaccine, Sudhakar said.Today, 10 vaccines have been approved and are available in India and it is a proud thing that among them is one home grown vaccine, the Covaxin developed by Bharat Biotech. Other vaccines are Covishield vaccine developed by Pune based Serum Institute of India who had tied up with Oxford University and AstraZeneca, Corbevax, Zydus Cadila which is the world's first DNA vaccine, Sudhakar said.The Minister said that India approached Pfizer and Moderna initially expecting that our vaccines may take time. "They agreed to provide the vaccine. But they refuse to take any responsibility or liability if something happens to our people. Our government was not willing to compromise with people's lives, and we decided to not provide the license unless they agreed to take liability."Speaking about Karnataka, he said, 10.54 crore vaccines are administered in the state. The second dose of the vaccine has been taken by 98 per cent of the people and another 32 lakh people are yet to take the second dose. He urged people to take the second dose and also the precautionary dose at the earliest.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Serum Institute Of India Pvt. LtdFOLLOW

Serum institute of india pvt. ltd, Latest News

British Prime Minister Boris Johnson on Friday highlighted the collaboration between Oxford-Astra Zeneca and the Serum Institute of India (SII) for the production of COVID-19 vaccines and emphasised that he has "the Indian jab" in his arms. ...

India's largest carmaker Maruti Suzuki said on Monday it has increased the prices of its entire model range by an average of 1.3 per cent due to a sharp increase in input costs. ...

(Prof) Dr Kannan Vishwanatth, noted academic researcher & Founder & Managing Director of Hong Kong based Rupus Global Limited, a globally acclaimed research-focused vertically integrated pharmaceutical Company, which contract manufactures active phar ...

Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna. ...

As some countries are presently reporting higher COVID-19 cases, Chief Executive Officer of Serum Institute of India (SII) Adar Poonawalla on Tuesday said that India is better prepared to face it now than it was in 2020. ...

Chief Executive Officer (CEO) of Serum Institute of India (SII) Adar Poonawalla on Tuesday informed that the company has exported nearly 40 million COVID vaccine doses to European countries and Australia, and said that the Covovax is the first vaccin ...

The decision to slash the prices of the precautionary dose of the COVID-19 vaccine Covishield, which is now available for all adults, was taken to make it more affordable, accessible and within reach of the masses, Chief Executive Officer (CEO) of Se ...

Bengaluru, April 12 Predictive studies opine that the 4th wave of the Covid-19 will start in June-July and ... ...